Clinical Trial Update: Retigabine (Adjunctive Therapy) Efficacy and Safety Study for Partial Onset Refractory Seizures in Epilepsy [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating retigabine as adjunctive therapy for partial-onset seizures in epilepsy has completed, with results posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Partial-onset Seizures

Drugs mentioned

• Retigabine (ezogabine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Seizures | Phase 3 | Status: COMPLETED | Results posted: 2011-10-25